IQOS Smoking Room at Manila International Airport

E-cigarette brand Al Fakher has recently listed its disposable hookah-style device, the Al Fakher Crown Bar 60K E-Hose X, across multiple online retail channels in the United States and the United Arab Emirates. The product features a mini water-bottle-like design, is rated for up to 60,000 puffs, comes with a 50ml e-liquid reservoir and a 1,000mAh rechargeable battery, and supports dual DTL/MTL vaping modes.

Hillsborough County Public Schools (HCPS) announced it will install vaping detection sensors across all high schools in Hillsborough County as part of what officials called a “proactive step” toward healthier and safer learning environments. District staff said the sensors are intended to help reduce vaping on campus, support student well-being and encourage positive behavior change.

The vaping brand OXBAR has recently listed its open-system, refillable pod device OX35K on its official website. The product features a “2ml built-in pod + two 10ml external refill bottles” e-liquid supply structure and supports top refilling, with a claimed puff count of up to 35,000. It is equipped with a 1000mAh built-in battery and offers dual power modes—BOOST and ECO—positioning the device to balance high-puff performance with an open-system form factor.

Imperial Brands PLC said on February 18, 2026 that it has launched its new Red, Gold and Silver iD heated tobacco sticks in Greece and Poland, with a broader rollout across Europe planned for 2026.

NSW Health has shut down five Inner West Sydney stores for 90 days after a major seizure of illicit cigarettes and illegal vapes, with two additional premises in Northern NSW also served closure notices. The action forms part of a broader crackdown that has seen 66 stores closed since new laws took effect in late 2025, with NSW Health warning further enforcement — including prosecution — may follow.

During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.